jjinvan said:
Keep in mind that one of the reasons they don't have good studies on long term effects of heroin use on the body is because they can't find many subjects who have been heroin users for a long time and don't have dozens of other health problems caused by things like dirty needles, unsanitary injections, bad nutrition, and generally doing dumb things because you are stoned all the time.
So, directly or indirectly, in almost every single case the 'side effect' of heroin addiction is living a miserable life as a walking zombie who is totally under control of the drug (and their dealer) who eventually dies either directly (overdose) or indirectly (HIV, drug violence, getting hit by a car cuz you were too stoned etc...) as a result of their addiction.
I've always said that if you REALLY want to go down the 'harm reduction' pathway to its logical conclusion, just set up dormatories in old warehouses with bunkbeds and IV drips of heroin and glucose etc.. together with feeding tubes and let the addicts lay there in bed and rot their lives away. That would be the ultimate in 'harm reduction'.
I say that every nickle spent on harm reduction could be better spent on preventing the problem in the first place.
You are ignoring the experiance in Europe. There are several European Countries where an addict can receive pure narcotics and clean needles.
http://issues06.emcdda.europa.eu/en/page006-en.html
The problem is, the programs don't work. While the Opiate use is going down due to the aging of the users, other drug use is on the rise.
http://www.drugwarfacts.org/internat.htm
"Current estimates suggest there are probably between 1.2 and 2.1 million problem drug users in the EU, of whom 850 000 to 1.3 million are likely to be recent injectors. Problem drug use prevalence estimates over time are patchy, making it difficult to identify long-term trends. However, in the EU-15 Member States, indicators broadly suggest that the rapid recruitment into heroin use that most countries had been experiencing peaked at some time in the early 1990s and was followed by a more stable situation thereafter. Although several countries have continued to report increases since 1999, there are recent signs that this situation is not uniform, with prevalence estimates showing no consistent picture at EU level. In particular, the new Member States deserve special mention, as they appear to have experienced heroin problems later and to have a more fluid situation."
Source: "Annual Report 2005: The State of the Drugs Problem in Europe," European Monitoring Centre for Drugs and Drug Addiction (Luxembourg: Office for Official Publications of the European Communities, 2005), p. 12.
"Additional sources of information for assessing problem drug use are the numbers of drug-related deaths and treatment demands. Analysis of drug-related deaths (most commonly due to opiate overdose) suggests that the victims constitute an ageing population, with recorded deaths among drug users younger than 25 having fallen since 1996. An important qualification is that data from the newer EU countries, although limited, show until recently an upwards trend in the proportion of deaths among those under 25, although a degree of stabilisation now appears to have occurred. Overall, although the number of drugrelated deaths in the EU remains at a historically high level, it seems likely to have peaked."
Source: "Annual Report 2005: The State of the Drugs Problem in Europe," European Monitoring Centre for Drugs and Drug Addiction (Luxembourg: Office for Official Publications of the European Communities, 2005), p. 12.
"Europe remains a major market for stimulant drugs, and indicators suggest that for Europe as a whole the trend in amphetamine, ecstasy and cocaine use continues to be upwards. Ecstasy has, on many measures, overtaken amphetamines as Europe’s second most used drug after cannabis. However, in the United Kingdom, which since the 1990s has on most measures had the highest prevalence rates of ecstasy and amphetamine use, both general and school population recent survey data suggest that rates of use of both drugs may be falling, quite dramatically for amphetamine and to a more limited extent for ecstasy. Nevertheless, prevalence rates in the United Kingdom remain relatively high in comparison with other countries, although the difference is now less marked, as a number of countries now report similar rates of use, resembling the picture described above for cannabis."
Source: "Annual Report 2005: The State of the Drugs Problem in Europe," European Monitoring Centre for Drugs and Drug Addiction (Luxembourg: Office for Official Publications of the European Communities, 2005), p. 12.
It seems that there exist people that don't want to use drugs in a "safe" manner and who will not use the drugs that their government is willing to supply and permit the use of.